-
-
Call more information
660-596-2224 -
Author: Barbara M. Rogers, MD, MBOE, FASA ASA Monitor August 2022, Vol. 86, 26. The COVID-19 pandemic has made health care workers and average citizens acutely aware of the transmissibility of deadly viruses. But have we gone beyond washing our hands before and after each patient encounter, a recommendation from the Centers for Disease Control and […]
Read MoreAuthors: Jennifer A. Rock-Klotz, MBA; Thomas R. Miller, PhD, MBA ASA Monitor August 2022, Vol. 86, 30–31. ASA’s Center for Anesthesia Workforce Studies (CAWS) reports trends in anesthesiology resident matches after the release of the National Resident Matching Program (NRMP) Results and Data report published in May or June each year (asamonitor.pub/3xD16Ye). This report summarizes data on […]
Read MoreAuthor: Gordon Glantz ASA Monitor August 2022, Vol. 86, 17. Joseph Szokol, MD, ASA’s Chief Health Policy Officer, would love nothing more than to say that he has not been directly affected by substance use disorders (SUDs), but that is sadly not the case. “Unfortunately, I have had to do interventions on several residents and attendings […]
Read MoreASA Monitor August 2022, Vol. 86, 12. Your next patient is a 75-year-old woman who fell while walking across her living room and sustained a right hip fracture. You plan to place a spinal anesthetic for the hip fracture repair surgery. According to a recent study, which of the following outcomes is MOST likely improved 60 […]
Read MoreASA Monitor August 2022, Vol. 86, 13. Trends FDA limits use of Johnson & Johnson COVID vaccine The U.S. Food and Drug Administration (FDA) has limited the authorized use of Johnson & Johnson’s Janssen COVID-19 vaccine to certain individuals due to risk of thrombotic events. The vaccine may still be used in people over the age […]
Read More